52 Biggest Movers From Yesterday

Gainers

• Roan Resources, Inc. ROAN shares jumped 21.1% to close at $1.49 on Tuesday after the company agreed to be acquired by Citizen Energy for $1.52 per share in cash.
• BioCardia, Inc. BCDA shares rose 20.6% to close at $3.98. BioCardia initiated commercial release of AVANCE™ Bi-Directional Steerable Introducer Sheath designed to enhance physician control for complex cardiac procedures.
• Conformis, Inc. CFMS climbed 19.4% to close at $2.22 after the company announced a development, license and distribution agreement with Stryker.
• Constellation Pharmaceuticals, Inc. CNST gained 17.5% to close at $7.59 after the company reported a $65 million private placement with new and existing investors.
• Geron Corporation GERN rose 12.8% to close at $1.50 after the company disclosed that it has received an FDA Fast Track designation for Imetelstat for relapsed/refractory myelofibrosis.
• HyreCar Inc. HYRE gained 12% to close at $2.80.
• Viveve Medical, Inc. VIVE shares gained 9.1% to close at $4.81 after falling 11.98% on Monday.
• Contango Oil & Gas Company MCF rose 7.9% to close at $3.00.
• Cellectis S.A. CLLS gained 7% to close at $11.13.
• McCormick & Company, Incorporated MKC rose 6.8% to close at $166.95
• Luokung Technology Corp. LKCO climbed 6.5% to close at $5.88.
• Upland Software, Inc. UPLD rose 6.3% to close at $37.06 after the company reported the acquisition of InGenius and raised its guidance.
• Sunworks, Inc. SUNW rose 6.3% to close at $2.52.
• Sibanye Gold Limited SBGL rose 5.6% to close at $5.70.
• Rayonier Advanced Materials Inc. RYAM shares jumped 4.2% to close at $4.51 after the company announced that it has reached agreement with lenders under its Senior Secured Credit Agreement and entered into an amendment through 2021.
• United States Steel Corporation X gained 3.3% to close at $11.93 after the company announced it will acquire 49.9% interest in Big River Steel for ~700 million in cash.

Check out these big penny stock gainers and losers

Losers

• China Customer Relations Centers, Inc. CCRC shares dipped 30% to close at $11.20 on Tuesday.
• Minerva Neurosciences, Inc. NERV shares fell 26.3% to close at $5.71 after the company delayed the results for its Schizophrenia drug.
• TD Ameritrade Holding Corporation AMTD fell 25.8% to close at $34.67 after Schwab reportedly eliminated commissions for mobile and web US stock, ETF and options trades.
• Jiayin Group Inc. JFIN tumbled 25.8% to close at $12.38.
• Reed's, Inc. REED shares fell 25.7% to close at $0.9664 after the company issued weak preliminary third-quarter sales guidance. The company also announced Chairman John Belo will serve as interim CEO.
• Ocugen Inc OCGN fell 24% to close at $2.19.
• NewLink Genetics Corporation NLNK fell 22% to close at $1.24 after announcing it has entered a merger agreement with Lumos Pharma to form a biopharmaceutical company focused on developing therapies to treat rare diseases.
• Axsome Therapeutics, Inc. AXSM shares declined 17.4% to close at $16.71.
• Cyclerion Therapeutics, Inc. CYCN dipped 16.5% to close at $10.12.
• E*TRADE Financial Corporation ETFC dropped 16.4% to close at $36.51 after Schwab reportedly eliminated commissions for mobile and web US stock, ETF and options trades.
• electroCore, Inc. ECOR fell 15.1% to close at $1.86.
• U.S. Well Services, Inc. USWS dropped 14.6% to close at $1.87.
• Calithera Biosciences, Inc. CALA fell 14.6% to close at $2.64.
• SpringWorks Therapeutics, Inc. SWTX dropped 14.5% to close at $18.53.
• Rockwell Medical, Inc. RMTI fell 14.5% to close at $2.36.
• Adamas Pharmaceuticals, Inc. ADMS dropped 14.4% to close at $4.38.
• Pacific Drilling S.A. PACD tumbled 13.8% to close at $3.37.
• Chimerix, Inc. CMRX shares declined 13.6% to close at $2.03. Chimerix announced an exclusive global license agreement with SymBio Pharma Ltd, under which the latter receivesworldwide rights to develop, manufacture and commercialize Chimerix's brincidofovir in all human indications, excluding the prevention and treatment of smallpox.
• Cue Biopharma, Inc. CUE dropped 13.5% to close at $7.29.
• Personalis, Inc. PSNL declined 13.2% to close at $12.74.
• scPharmaceuticals Inc. SCPH fell 12.8% to close at $5.16.
• cbdMD, Inc. YCBD tumbled 12.6% to close at $3.46.
• Genfit SA GNFT shares fell 12.4% to close at $15.25 after rising 8.88% on Monday.
• GTT Communications, Inc. GTT shares declined 11.5% to close at $8.34.
• Pier 1 Imports, Inc. PIR dropped 11.4% to close at $8.61.
• Syros Pharmaceuticals, Inc. SYRS dipped 10.7% to close at $9.27.
• AnaptysBio, Inc. ANAB fell 10.4% to close at $31.35 after reporting topline data from interim analyst of GALLOP phase 2 clinical trial of ANB019 monotherapy in moderate-to-severe generalized pustular psoriasis.
• Peloton Interactive, Inc. PTON fell 10.3% to close at $22.51.
• Kezar Life Sciences, Inc. KZR dropped 10.1% to close at $2.95.
• AnaptysBio, Inc. ANAB dipped 9.6% to $31.68 after the company announced Phase 2 trial data for its GALLOP.
• The Charles Schwab Corporation SCHW dropped 9.4% to $37.90 after the company announced it will eliminate mobile/web US commissions.
• Livongo Health, Inc. LVGO shares dropped 8.7% to close at $15.92.
• Synthorx, Inc. THOR declined 8.7% to close at $14.86.
• Resonant Inc. RESN dropped 8.1% to close at $2.73.
• LexinFintech Holdings Ltd. LX fell 7.6% to close at $9.27.
• Hexcel Corporation HXL fell 6.4% to close at $76.90.